Brief: Rhythm Biosciences Secures Strategic Us Partnership With Cancer IQ
28/01/2026 01:37
Jan 28 (Reuters) - Rhythm Biosciences Ltd RHY.AX: SECURES STRATEGIC US PARTNERSHIP WITH CANCER IQ Further company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Biosciences
See all newsBrief: Rhythm Biosciences Says Gavin Fox-Smith Resigns As Chair
Brief: Rhythm Biosciences Announces Appointment Of Non-Executive Directors
Australia's Rhythm Biosciences rises on accelerating commercialisation of cancer test
Brief: Rhythm Biosciences Executes Distribution Agreement For Genetype
Brief: Rhythm Biosciences Seeks Trading Halt